Journal of Vascular and Interventional Radiology
Volume 21, Issue 8 , Pages 1173-1184 , August 2010

The Safety and Effectiveness of the Retrievable Option Inferior Vena Cava Filter: A United States Prospective Multicenter Clinical Study

  • Matthew S. Johnson, MD

      Affiliations

    • Department of Radiology, Indiana University School of Medicine, 550 University Blvd., Indianapolis, IN 46202
    • Corresponding Author InformationAddress correspondence to M.S.J.
    • ,
  • Albert A. Nemcek Jr, MD

      Affiliations

    • Department of Radiology, Section of Interventional Radiology, Northwestern Memorial Hospital, Chicago, Illinois
    • ,
  • James F. Benenati, MD

      Affiliations

    • Baptist Cardiac and Vascular Institute, Miami, Florida
    • ,
  • Dirk S. Baumann, MD

      Affiliations

    • Peninsula Vein Clinic, Mill–Peninsula Medical Center, Burlingame, California
    • ,
  • Bart L. Dolmatch, MD

      Affiliations

    • Division of Interventional Radiology, University of Texas Southwestern Medical Center, Dallas, Texas
    • ,
  • John A. Kaufman, MD

      Affiliations

    • Dotter Interventional Institute, Oregon Health and Science University, Portland, Oregon
    • ,
  • Mark J. Garcia, MD

      Affiliations

    • Section of Vascular and Interventional Radiology, Christiana Hospital, Newark, Delaware
    • ,
  • Michael S. Stecker, MD

      Affiliations

    • Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts
    • ,
  • Anthony C. Venbrux, MD

      Affiliations

    • Department of Radiology, George Washington University, Washington DC
    • ,
  • Ziv J. Haskal, MD

      Affiliations

    • Division of Vascular and Interventional Radiology, University of Maryland Medical Center, Baltimore, Maryland
    • ,
  • Rui L. Avelar, MD

      Affiliations

    • Angiotech Pharmaceuticals, Vancouver, British Columbia, Canada

Received 17 November 2009 ,Revised 27 February 2010 ,Accepted 3 April 2010.

References 

  1. Kinney TB. Update on inferior vena cava filters. J Vasc Interv Radiol. 2003;14:425–440
  2. Kaufman JA, Kinney TB, Streiff MB, et al. Guidelines for the use of retrievable and convertible vena cava filters: report from the Society of Interventional Radiology Multidisciplinary Consensus Conference. J Vasc Interv Radiol. 2006;17:449–459
  3. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ. Antithrombotic therapy for venous thromboembolic disease (American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)). Chest. 2008;133(suppl):454S–545S
  4. Decousus H, Leizorovicz A, Parent F, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med. 1998;338:409–415
  5. PREPIC Study Group. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prévention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study. Circulation. 2005;112:416–422
  6. Segal JB, Streiff MB, Hofmann LV, Thornton K, Bass EB. Management of venous thromboembolism: a systematic review for a practice guideline. Ann Intern Med. 2007;146:211–222
  7. Kaufman JA. Optional vena cava filters: what, why, and when. Vascular. 2007;15:304–313
  8. Kaufman JA, Rundback JH, Kee ST, et al. Development of a research agenda for inferior vena cava filters: proceedings from a multidisciplinary research consensus panel. J Vasc Interv Radiol. 2009;20:697–707
  9. Participants in the Vena Caval Filter Consensus Conference. Recommended reporting standards for vena caval filter placement and patient follow-up. J Vasc Interv Radiol. 2003;14(Suppl):S427–S432
  10. Millward SF, Grassi CJ, Kinney TB, et al. Technology Assessment Committee of the Society of Interventional Radiology Reporting standards for inferior vena caval filter placement and patient follow-up: supplement for temporary and retrievable/optional filters. J Vasc Interv Radiol. 2005;16:441–443
  11. Sacks D, McClenny TE, Cardella JF, Lewis CA. Society of Interventional Radiology Clinical Practice Guidelines (Introduction). J Vasc Interv Radiol. 2003;14(Suppl):S199–S202
  12. Grassi CJ, Swan TL, Cardella JF, et al. Society of Interventional Radiology Standards of Practice Committee Quality improvement guidelines for percutaneous permanent inferior vena cava filter placement for the prevention of pulmonary embolism. J Vasc Interv Radiol. 2003;14(Suppl):S271–S275
  13. Clopper CJ, Pearson ES. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika. 1934;26:404–413
  14. Streiff MB. Vena caval filters: a review for intensive care specialists. J Intens Care Med. 2003;18:59–79
  15. Patel SH, Patel R. Inferior vena cava filters for recurrent thrombosis: current evidence. Tex Heart Inst J. 2007;34:187–194
  16. Chung J, Owen RJT. Using inferior vena cava filters to prevent pulmonary embolism. Can Fam Physician. 2008;54:49–55
  17. Kim HS, Young MJ, Narayan AK, Hong K, Liddell RP, Streiff MB. A comparison of clinical outcomes with retrievable and permanent inferior vena cava filters. J Vasc Interv Radiol. 2008;19:393–399
  18. Memtsoudis SG, Besculides MC, Gaber L, et al. Risk factors for pulmonary embolism after hip and knee arthroplasty: a population-based study. Int Orthop. 2008;33:1739–1745
  19. Cushman M. Epidemiology and risk factors for venous thrombosis. Semin Hematol. 2007;44:62–69

 From the SIR 2009 Annual Meeting.

 This study was sponsored by Rex Medical (Conshohocken, Pennsylvania). M.S.J. serves as a consultant to Rex Medical, CeloNova BioSciences (Newnan, Georgia), Cook (Bloomington, Indiana), Lutonix (Maple Grove, Minnesota), Boston Scientific Corporation (Natick, Massachusetts), MDS Nordion (Ottawa, Canada), and Sirtex Medical (Lane Cove NSW, Australia). A.A.N. serves as a consultant to B. Braun Interventional (Bethlehem, Pennsylvania). J.F.B serves on the medical advisory boards of Amaranth Medical (Mountain View, California), Cordis Endovascular (Miami Lakes, Florida), and EndoVention (San Francisco, California) and as the Chief Medical Officer for Endovascular Forum (Boston, Massachusetts); and is a stockholder of Ekos (Bothell, Washington). D.S.B. serves on the advisory board of Cordis Endovascular and as a consultant and speaker for Bard Peripheral Vascular (Tempe, Arizona). B.L.D. serves as a consultant and speaker for Bard Peripheral Vascular and as a consultant to Covidien (Mansfield, Massachusetts) and on the medical advisory boards of Vital Access (Salt Lake City, Utah) and Endovascular Forum. J.A.K. serves on the medical board of Hatch Medical (Duluth, Georgia) and as a consultant to AGA Medical (Plymouth, Minnesota) and receives research support from W.L. Gore and Associates (Flagstaff, Arizona), VNUS Medical Technologies (San Jose, California), LeMaitre Vascular (Burlington, Massachusetts), and Rex Medical. Z.JH. serves on the scientific advisory board of W.L. Gore and Associates and on the medical advisory boards of Endovascular Forum and Elcam Medical (Hackensack, New Jersey) and as a consultant for Bard Peripheral Vascular, and receives research support from Bard Peripheral Vascular. R.L.A. is an employee of, and stockholder in, Angiotech Pharmaceuticals (Vancouver, British Columbia, Canada). None of the other authors have identified a conflict of interest.

PII: S1051-0443(10)00328-3

doi: 10.1016/j.jvir.2010.04.004

Journal of Vascular and Interventional Radiology
Volume 21, Issue 8 , Pages 1173-1184 , August 2010

Article Tools

* Image Usage & Resolution